Dimensions of FSW Tool. حسب Shaheer Ahmed Khan (17797647)

الموضوعات:

Dog-bone specimens after tensile testing. حسب Shaheer Ahmed Khan (17797647)

الموضوعات:

Tensile strength and joint efficiency of ABS and PC welded samples. حسب Shaheer Ahmed Khan (17797647)

الموضوعات:

(a) Data Acquisition System (b) Real time data collection. حسب Shaheer Ahmed Khan (17797647)

الموضوعات:

Hardness Profile of ABS Polymers at 800 and 1200 rpm. حسب Shaheer Ahmed Khan (17797647)

الموضوعات:

Dog-bone specimens before tensile testing. حسب Shaheer Ahmed Khan (17797647)

الموضوعات:

Tensile Strength (MPa) of ABS Polymers at 800 and 1200 rpm. حسب Shaheer Ahmed Khan (17797647)

الموضوعات:

Different characterization techniques and their uses. حسب Shaheer Ahmed Khan (17797647)

الموضوعات:

SEM Samples of FSW Joints: (i) ABS (800 rpm,10 mm/min) [(a) Cross-sectional View, (b) 250X, (c)1000X} (ii) ABS (1200 rpm,10 mm/min) [(d) Cross-sectional View, (e) 250X, (f)1000X} (... حسب Shaheer Ahmed Khan (17797647)

الموضوعات:

Experimental run of FSW on CNC milling machine. حسب Shaheer Ahmed Khan (17797647)

الموضوعات:

Maximum Axial Force values of PC Polymers at 800 and 1200 rpm. حسب Shaheer Ahmed Khan (17797647)

الموضوعات:

KO of iPLA₂γ attenuates development of albuminuria in STZ-induced diabetic nephropathy. حسب Andrey V. Cybulsky (4007012)

الموضوعات:

Control (Ctrl) STZ mice show changes in glomerular morphology. حسب Andrey V. Cybulsky (4007012)

الموضوعات:

Control (Ctrl) GECs are more susceptible to injury compared to iPLA₂γ KO GECs. حسب Andrey V. Cybulsky (4007012)

الموضوعات:

iPLA₂γ KO mice show increased glomerular autophagy. حسب Andrey V. Cybulsky (4007012)

الموضوعات:

Podocyte numbers in control and iPLA₂γ KO mice (WT1-positive cells). حسب Andrey V. Cybulsky (4007012)

الموضوعات:

STZ increases glomerular matrix expansion. حسب Andrey V. Cybulsky (4007012)

الموضوعات:

Primary data. حسب Andrey V. Cybulsky (4007012)

الموضوعات:

Overview of the parameters used in the model. حسب Albertus Constantijn Sloof (20405090)

"…Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …"

Mortality rates per lifecycle stage [28]. حسب Albertus Constantijn Sloof (20405090)

"…Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …"